A Modern Approach to the Treatment of Cancer and Other Serious Diseases

At Nativis we’re making targeted, non-invasive treatment a reality. Our technology has the potential to fight cancer and other diseases as effectively as pharmaceuticals or biologics without the side effects. How is this possible?


Founded in 2002, Nativis is a clinical-stage bio-electronics company pioneering a novel platform technology to treat cancer and other serious diseases. With the help of some of the top minds in science and medicine, we’re leading an evolution in health care by giving physicians a powerful new tool for fighting disease and patients unprecedented hope for recovery. Clinical trials are currently under way.

More About Us

Note: Nativis Voyager RFE System for rGBM is an investigational medical device. Limited by Federal (or United States) law to investigational use only.

Scientific Platform

Our proprietary ultra-low Radio Frequency Energy (ulRFE) technology produces a cognate of solvated molecules by measuring and recording their electrostatic potential as an oscillating magnetic field. The ulRFE cognate is delivered locally and non-systemically via a device. To date, no adverse effects or toxicity related to the device have been observed.

See Our Science